It has been an extraordinary time for digital medicine and the new year will bring continued growth. The key drivers are expanded patient engagement as well as institutional investment with the ultimate goal of reducing costs. Big pharma, payers and insurance companies have recognized the business benefits of patient empowerment. Digital applications are helping patients become better decision makers for their own health by providing personalized insights. As companies and legislators seek to reduce health costs, digital tools are ever more attractive options to drive efficiencies. Looking forward, continued growth will be fueled by large institutions seeking partnerships, product development and better tools for clinical trials, further changes at the FDA to help demystify digital therapeutics, and steady flow of investor money from both venture capital and public markets.
Read the full article: Digital Healthcare Growth Drivers in 2020 //